Literature DB >> 8940015

CD45 modulates phosphorylation of both autophosphorylation and negative regulatory tyrosines of Lyn in B cells.

S Yanagi1, H Sugawara, M Kurosaki, H Sabe, H Yamamura, T Kurosaki.   

Abstract

CD45 is a tyrosine phosphatase that is required for normal B cell receptor (BCR)-mediated signaling. It has been shown that Src-family tyrosine kinases such as Lyn could be a potential substrate for CD45. In vitro studies indicate that activities of Src family tyrosine kinases are regulated by tyrosine phosphorylation; C-terminal phosphorylation is inhibitory, and autophosphorylation is stimulatory. We report here that both autophosphorylation and C-terminal negative regulatory tyrosines of Lyn were hyperphosphorylated in CD45-deficient DT40 B cells. In this mutant cell, BCR-induced protein-tyrosine phosphorylation and calcium mobilization were severely compromised, as seen in Lyn-deficient cells. Consistent with this observation, Lyn activation upon receptor ligation was profoundly decreased in CD45-deficient cells. Taken together, our results suggest that dephosphorylation of tyrosine residues at both autophosphorylation and negative regulatory sites is mediated by CD45 in vivo, and that dephosphorylation of C-terminal tyrosine is a prerequisite for participation of Lyn in BCR signaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940015     DOI: 10.1074/jbc.271.48.30487

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Membrane domains and the immunological synapse: keeping T cells resting and ready.

Authors:  Michael L Dustin
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 2.  Models of signal transduction through the B-cell antigen receptor.

Authors:  Roland Geisberger; Reto Crameri; Gernot Achatz
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

3.  Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-alpha in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56lck tyrosine kinase.

Authors:  C- L Yu; H-S Yu; K-H Sun; S-C Hsieh; C-Y Tsai
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 4.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

5.  Expression of the p56(Lck) Y505F mutation in CD45-deficient mice rescues thymocyte development.

Authors:  J R Seavitt; L S White; K M Murphy; D Y Loh; R M Perlmutter; M L Thomas
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  Visualizing lipid raft dynamics and early signaling events during antigen receptor-mediated B-lymphocyte activation.

Authors:  Neetu Gupta; Anthony L DeFranco
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

7.  The lectin Jacalin induces human B-lymphocyte apoptosis through glycosylation-dependent interaction with CD45.

Authors:  Bruce Yong Ma; Kaori Yoshida; Makoto Baba; Motohiro Nonaka; Shogo Matsumoto; Nobuko Kawasaki; Shinji Asano; Toshisuke Kawasaki
Journal:  Immunology       Date:  2008-10-30       Impact factor: 7.397

8.  The protein tyrosine phosphatase CD45 is required for interleukin 6 signaling in U266 myeloma cells.

Authors:  Qun Zhou; Yuan Yao; Solveig G Ericson
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

9.  A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.

Authors:  Mariam Hammadi; Jacques-Olivier Pers; Christian Berthou; Pierre Youinou; Anne Bordron
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

10.  The role of protein tyrosine phosphatases in the regulation of allergic asthma: implication of TC-PTP and PTP-1B in the modulation of disease development.

Authors:  Philippe Pouliot; Sébastien Bergeron; André Marette; Martin Olivier
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.